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In this issue of Cell Host & Microbe, Jensen et al. (2011) show that clonal lineages of Toxoplasma gondii have
evolved distinct ways of subverting their favored host cell, themacrophage. The results suggest that T. gondii
and the ROP kinases can be used to probe immune signaling pathways.Toxoplasma gondii is an apicomplexan
parasite that can infect most mammals
and fulfills all the requirements of an effi-
cient parasite: it rarely causes clinical
disease, is easy to transmit, and has elab-
orate mechanisms of subverting and
manipulating its hosts. The life cycle of
T. gondii is complex because it involves
rodents, humans, and other mammals as
‘‘intermediate’’ hosts and the domestic
cat as the ‘‘definitive’’ host, where the
parasite’s sexual cycle occurs (Sibley
and Ajioka, 2008). Within different hosts,
parasite development consists of acute
(tachyzoite), latent (bradyzoite), and
spore-forming (oocyst) stages. For hu-
mans, accidental oral ingestion of small
numbers of oocysts originating from cat
feces is a main infection source. This
route of infection will be familiar to the
general public, as T. gondii is one of the
few protozoa to gain a prominent role in
a feature film (Trainspotting, 1996), where
its insidious side was on display in the
immunocompromised. T. gondii remains
a major problem in the immunocompro-
mised, highlighting the fact that although
huge numbers of people are infected
with T. gondii, infections generally remain
subclinical because of a combination of
immune control and parasite-mediated
subversion of the host to enable long-
term survival.
Recent work on T. gondii biology has
seen a fascinating convergence of new
ideas and data. First, analysis of the global
population structures of T. gondii showed
that three clonal lineages exist, but only
one, the type II strains, are dominant in
humans (Sibley and Ajioka, 2008). This
finding is curious because cat domestica-
tion first occurred in the eastern Mediter-
ranean and Egypt 10,000 years ago,
suggesting T. gondii quickly harnessedanew life cycle stageonce theopportunity
became available. Second, the differ-
ences between the clonal lineages were
tied to polymorphic proteins, including
ROP proteins injected into host cells
from specialized organelles called rhop-
tries and ‘‘dense granules’’ (Boothroyd
and Dubremetz, 2008). Third, several
ROP proteins, including ROP16 and
ROP18, were shown to be kinases that
could phosphorylate host proteins and
thereby subvert host cytokine signaling
pathways (Boothroyd and Dubremetz,
2008). These results set the stage for the
work of Jensen et al. (Jensen et al.,
2011), who set out to investigate thediffer-
ences between type I, II, and III strains in
terms of macrophage activation. At this
point it is important to note that although
T. gondii can infect any kind of nucleated
cell, macrophages and related mononu-
clear phagocytes are its preferred target
in vivo, and that the parasite seems to
have multiple ways of avoiding immune-
mediated killing. Therefore, macrophage-
centric research is essential to understand
the basic strategies of the parasite-host
interaction.
Jensen et al. began by infecting macro-
phage cell lines with type I, II, and III
strains, followed by gene expression
profiling. The key finding was that type I
and III strains elicited a gene expression
profile closely allied to alternatively acti-
vated macrophages (AAMs, also known
as M2 macrophages), while type II strains
caused macrophages to adopt a classi-
cally activated phenotype (CAMs, also
known as M1 macrophages). AAMs are
enriched in Th2 inflammation such as
worm infections and asthma because
these immune responses are associated
with IL-4 and IL-13 production, eosino-
philia, and mucous production driven byCell Host & MicrobTh2-polarized CD4+ T cell responses
(Gordon and Martinez, 2010). Macro-
phages respond to IL-4 and IL-13 by acti-
vating signaling pathways emanating
from the IL-4 and IL-13 receptors,
including the STAT6 signaling pathway.
AAMs are essential for several types of
Th2 responses to worms, although the
mechanisms responsible remain largely
unknown. However, two AAM-linked
genes, arginase-1 (encoded by Arg1)
and RELM-a (encoded by Retnla), have
irreplaceable roles in suppression of
excessive immune responses to worms
(Murray and Wynn, 2011). Jensen et al.
then tested the underlying mechanisms
T. gondii uses to polarize macrophages.
They found that the type I/III ROP16
kinase phosphorylates STAT6 and there-
fore bypasses the requirement for exoge-
nous IL-4 and IL-13 (Figure 1). By
contrast, type II strains rely on the dense
granule protein GRA15 to activate NF-kB
and drive the proinflammatory CAM
gene expression program characterized
by increased expression of genes such
as Il23a, Il6, and a multitude of other
NF-kB-regulated genes (Jensen et al.,
2011; Rosowski et al., 2011). The
dichotomy between the type I/III and
type II strains was also tested by an
elegant series of engineered parasite
strains to enforce expression of the type
I ROP16 in type II strains and in type II
strains deleted for GRA15 (Figure 1).
Jensen et al. found that macrophage
polarization closely followed the combi-
nations of ROP16 and GRA15, and they
concluded that ROP16 is sufficient to
elicit an AAM gene expression program
so long as GRA15 is absent. An extension
of these findings concerns the require-
ment for STAT6. If ROP16 is sufficient to
drive AAM gene expression by STAT6e 9, June 16, 2011 ª2011 Elsevier Inc. 445
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Figure 1. Host Signaling Manipulation by Clonal Types of T. gondii
ROP proteins are delivered into the cell during and after parasite entry and differentially activate host signaling pathways. Type I strains use ROP16 to phosphor-
ylate and activate STAT3 and STAT6, leading to activation of an AAM-type gene expression profile (left). By contrast, the type II ROP16 has a negligible effect on
STAT3 and STAT6. Instead, GRA15 activates NF-kB to drive a CAM-type response, while the type I GRA15 has a negligible effect on NF-kB activation in type I
strains where ROP16 activates STAT3 and STAT6. The parasite entry pathway and structure are modified from Boothroyd and Dubremetz (2008).
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tial. Indeed, Jensen et al. showed that
arginase activity was lost in STAT6-
deficient macrophages infected with all
the engineered strains.
Although the results of Jensen et al.
seem straightforward, there are several
caveats in the study that should stimulate
new experiments with the ROP16/GRA15
system. First, Jensen et al. conclude that
the induction of Arg1 expression as part
of the AAM gene expression program
provides an advantage for the type I/III
parasites. However, infection of macro-
phage-specific Arg1 conditional knock-
outs with a type II strain is strongly protec-
tive in terms of survival (El Kasmi et al.,
2008). Therefore, Arg1 is also involved in
type II infections, and as Arg1 can be
induced as part of the CAM gene expres-
sion program, it is too early to tell if Arg1 is
an obligate requirement for the natural life
cycle of type I/III strains in mammals or
merely a marker of macrophages under-
going parasite-directed STAT6 activation.
However, the engineered T. gondii strains
developed by Jensen et al. provide an
unparalleled opportunity to dissect host-
pathogen interplay should they be applied
to the macrophage-specific Arg1 condi-
tional knockouts. Second, type I ROP16
is also a potent kinase for STAT3 (Yama-446 Cell Host & Microbe 9, June 16, 2011 ª2moto et al., 2009). Since STAT3 can acti-
vate a variety of gene expression pro-
grams, especially the IL-10-dependent
anti-inflammatory response, it will be
important to factor in effects elicited by
both STAT3 and STAT6 phosphorylation
on macrophage gene expression. A final
point also concerns the activation of
STAT3 by T. gondii. Several years ago,
Denkers and colleagues showed that
T. gondii activates STAT3 tyrosine phos-
phorylation within seconds of engage-
ment with macrophages (Butcher et al.,
2005). It seems unlikely that this imme-
diate activation could be mediated by
ROP16, but the overall STAT3 activation
could be tested with the T. gondii
ROP16-engineered strains. Related to
this point, Takeda and colleagues have
shown that a single amino acid difference
determines strong type I ROP16 kinase
activity on STAT3 relative to the type II
ROP16 (Yamamoto et al., 2009). Collec-
tively, T. gondii has evolved multiple
ways to activate both STAT3 and
STAT6, but the overall impact of this
manipulation on T. gondii fitness remains
to be established.
The results reported by Jensen et al.
thus highlight some important gaps in
knowledge about the overall biology of
T. gondii’s interplay with humans and011 Elsevier Inc.other intermediate hosts as well as with
the definitive hosts. First, it remains
unclear why type II strains are so success-
ful if they are such powerful activators of
macrophages and elicit strong IL-12-
and Th1-dependent immunity. The elabo-
ration of such a strong antiparasite
response seems counterintuitive and is
generally rationalized as a parasite
strategy to achieve latency. However, as
T. gondii has evolved so quickly with
humans and their pets, it seems likely
that this is a guess, and detailed work is
needed on the natural transmission of
genetically manipulated clonal strains.
Second, T. gondii is orally transmitted
andmust therefore first engage themono-
nuclear phagocyte pool of the gut, along
with monocytes attracted to the infection
site (Dunay and Sibley, 2010). Gut macro-
phages are substantially different from the
easy-to-generate, bone marrow-derived
macrophages used in many in vitro exper-
iments; for example, gut macrophages
are constitutively exposed to IL-10 to
prevent excessive responses to the gut-
driven microbial products and therefore
require constant STAT3 signaling to acti-
vate the anti-inflammatory response. The
potential effect of the ROP kinases in
these cells in these cells is intriguing. It
will therefore it will be important to
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vated by T. gondii ROP kinases in tissue
macrophages as a complement to in vitro
studies. Third, the clear lines of CAM and
AAM macrophage activation are unlikely
to occur in humans or even in rodent
tissue macrophages: human macro-
phages and DCs do not readily activate
either Arg1 or iNOS, and therefore the
interplay between T. gondii and human
cells seems an important direction for
the field.
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Integration of reverse transcribed HIV-1 DNA into the host genome, catalyzed by HIV-1 integrase, represents
an obligate step in establishing productive viral infection. Allouch et al. (2011) identify KAP1 (TRIM28) as an
interaction partner of acetylated integrase. KAP1, in complex with HDAC1, represses HIV-1 integration
through specific deacetylation of HIV-1 integrase.Like all retroviruses, HIV must reverse
transcribe its RNA genome into DNA and
insert this DNA into the host cell genome.
This process, known as integration, is an
essential early step in establishing a stable
and productive infection. The integration
process is catalyzed by HIV-1 integrase
(IN) and takes place within the preintegra-
tion complex (PIC), a large macromolec-
ular structure, which contains approxi-
mately 10 kb of viral DNA, along with viral
andcellular proteins.While in vitro integra-
tion can be solely driven by IN, cellular
cofactors clearly play an essential role for
in vivo HIV-1 integration. Since integration
is a vital step in HIV-1 infection, develop-
ment of antiviral drugs against IN activity
and identification of candidate cofactors
of retroviral integration remain a key focus
of investigations.
Considerable effort has been made to
identify viral and cellular components
involved in HIV-1 integration by variousassays including in vitro reconstitution of
enzymatic activity of salt-stripped PICs,
yeast two-hybrid screens, andcoimmuno-
precipitation. These in vitro assays have
identified an arsenal of candidate cofac-
tors and have provided insights into the
cellular pathways and complexes previ-
ously unsuspected of being involved in
retroviral integration. One of the better
studied cellular cofactors for integration
is LEDGF/p75, a cellular stress-response
factor and transcriptional coactivator (Ge
et al., 1998). An unexpected link between
LEDGF/p75 and HIV was initially identified
following a coimmunoprecipitation study
of the HIV-1 IN complexes present in
nuclei of human cells that stably overex-
press the HIV-1 IN from a synthetic gene
(Cherepanov et al., 2003). An in vivo role
for LEDGF/p75 in HIV-1 replication has
been validated by several groups. For
other putative cofactors of HIV-1 integra-
tion, it remains a challenge to clearlyestablish functional relevance of potential
cellular factors of viral integration in vivo.
In this issue, the Cereseto laboratory
(Allouch et al., 2011) identifies a cellular
factor that posttranslationally modulates
HIV-1 IN activity.
A prior study from the Cereseto labora-
tory (Cereseto et al., 2005) identified a
function for p300, a cellular acetyltrans-
ferase known to acetylate histones and
regulate chromatin, in mediating acetyla-
tion of HIV-1 IN. Acetylation by p300
was shown to increase both IN affinity
for DNA and strand transfer activity, thus
suggesting relevance for IN posttransla-
tion modification by acetylation. Three
lysine residues, located at positions 264,
266, and 273 in the C-terminal domain
of IN, were identified as the acetylation
target sites (Cereseto et al., 2005). A mu-
tant virus in which arginine substitutions
were introduced at p300-targeted IN
lysines was shown to be less efficient ate 9, June 16, 2011 ª2011 Elsevier Inc. 447
